{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:11Z","timestamp":1789609091735,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>As one of the leading causes of heart failure, dilated cardiomyopathy (DCM) is characterized by dysfunctional muscle contraction and enlarged ventricular chamber. Patients with DCM have been shown to respond well to immunoadsorption (IA) therapies. However, the efficacy and safety of IA treatment for DCM patients remained to be evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This study was designed in accordance with the Preferred Reporting Items for Systematic Review and Meta-analysis. We searched the databases such as Cochrane library, Cochrane Central Register of Controlled Trials, Embase, OVID, and Web of Science from January 1990 to March 20, 2020, and performed meta-analysis using Stata MP Version 13.0.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We performed meta-analysis on 12 studies that included a total of 395 patients with DCM. Overall, IA treatment significantly improved the left ventricular ejection fraction (6.01, 95% confidence interval [CI] [4.84\u20137.19]), reduced the left ventricular end diastolic diameter (\u20133.62, 95% CI [\u20134.06 to \u20133.19]), reduced severity of symptoms according to the New York Heart Association (NYHA) functional classification (\u20131.37, 95% CI [\u20131.73 to \u20131.02]) as compared with the controls, but had no effect on values for safety parameters (1.13, 95% CI [0.58\u20132.19]).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Results of this meta-analysis indicated that the IA treatment can improve the left ventricular ejection fraction, reduce left ventricular end diastolic diameter, and thus improve clinical outcome in DCM patients. However, further evidence are required to validate the relative safety of IA treatment. Multi-center, double blind studies should be conducted to elucidate the precise effect of IA treatment in DCM patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026475","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T14:45:45Z","timestamp":1625064345000},"page":"e26475","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Immunoadsorption treatment for dilated cardiomyopathy"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7877-010X","authenticated-orcid":false,"given":"Ru-tao","family":"Bian","sequence":"first","affiliation":[{"name":"Department of Cardiology, Henan University of Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Henan University of Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-yu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephropathy, Zhengzhou Traditional Chinese Medicine Hospital, Zhengzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1103","article-title":"Evolving concepts in dilated cardiomyopathy","volume":"20","author":"Merlo","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The diagnosis and evaluation of dilated cardiomyopathy","volume":"67","author":"Japp","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1172-1-27","article-title":"Cardiomyopathy, familial dilated","volume":"1","author":"Taylor","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ejhf.1461","article-title":"Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Seferovi\u0107","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"3C","DOI":"10.1016\/j.amjcard.2005.03.006","article-title":"Immune activation in chronic heart failure","volume":"95","author":"Torre-Amione","year":"2005","journal-title":"Am J Cardiol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice","volume":"291","author":"Nishimura","year":"2001","journal-title":"Science"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10741-018-9709-9","article-title":"Immunomodulatory treatment for lymphocytic myocarditis - a systematic review and meta-analysis","volume":"23","author":"Winter","year":"2018","journal-title":"Heart Fail Rev"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.atherosclerosissup.2015.02.023","article-title":"Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus","volume":"18","author":"Dandel","year":"2015","journal-title":"Atheroscler Suppl"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/sji.12000","article-title":"The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy","volume":"77","author":"Bulut","year":"2013","journal-title":"Scand J Immunol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00109-007-0263-5","article-title":"Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy","volume":"85","author":"Kallwellis-Opara","year":"2007","journal-title":"J Mol Med (Berl)"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.CIR.101.4.385","article-title":"Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy","volume":"101","author":"M\u00fcller","year":"2000","journal-title":"Circulation"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.atherosclerosissup.2012.10.028","article-title":"Ig apheresis for the treatment of severe DCM patients","volume":"14","author":"Pokrovsky","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1744-9987.2006.00343.x","article-title":"Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy","volume":"10","author":"Staudt","year":"2006","journal-title":"Ther Apher Dial"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(00)00568-4","article-title":"Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy","volume":"35","author":"Felix","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ahj.2010.01.012","article-title":"Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy","volume":"159","author":"Herda","year":"2010","journal-title":"Am Heart J"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijcard.2003.12.003","article-title":"Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy","volume":"97","author":"Knebel","year":"2004","journal-title":"Int J Cardiol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/01.CIR.103.22.2681","article-title":"Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution","volume":"103","author":"Staudt","year":"2001","journal-title":"Circulation"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.CIR.103.2.220","article-title":"Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure","volume":"103","author":"Gullestad","year":"2001","journal-title":"Circulation"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00380-013-0368-4","article-title":"Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance","volume":"29","author":"Kishimoto","year":"2013","journal-title":"Heart Vessels"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.CIR.103.18.2254","article-title":"Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy","volume":"103","author":"McNamara","year":"2001","journal-title":"Circulation"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/biom9110654","article-title":"Use of cardiac biomarkers for monitoring improvement of left ventricular function by immunoadsorption treatment in dilated cardiomyopathy","volume":"9","author":"Weinmann","year":"2019","journal-title":"Biomolecules"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jacc.2019.12.058","article-title":"Emerging techniques for risk stratification in nonischemic dilated cardiomyopathy: JACC review topic of the week","volume":"75","author":"Marrow","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/14779072.2015.990385","article-title":"Immunoadsorption therapy in dilated cardiomyopathy","volume":"13","author":"Felix","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jjcc.2016.07.014","article-title":"Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: results from the observational prospective Bad Berka Registry","volume":"69","author":"Ohlow","year":"2017","journal-title":"J Cardiol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jca.21446","article-title":"Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety","volume":"31","author":"Yoshikawa","year":"2016","journal-title":"J Clin Apher"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/eurjhf\/hfs123","article-title":"Long-term benefits of immunoadsorption in (1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy","volume":"14","author":"Dandel","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/eurheartj\/ehs330","article-title":"Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy","volume":"34","author":"Ameling","year":"2013","journal-title":"Eur Heart J"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ahj.2004.11.002","article-title":"Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption","volume":"150","author":"Staudt","year":"2005","journal-title":"Am Heart J"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2016.06.061","article-title":"Aptamer BC 007 - a broad spectrum neutralizer of pathogenic autoantibodies against G-protein-coupled receptors","volume":"789","author":"Haberland","year":"2016","journal-title":"Eur J Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:35:03Z","timestamp":1746336903000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026475"}},"subtitle":["A PRISMA-compliant systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":31,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026475","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"assertion":[{"value":"2020-11-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}